Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma
- PMID: 26351338
- PMCID: PMC4979086
- DOI: 10.1200/JCO.2015.61.6995
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma
Abstract
Human papillomavirus (HPV) is now established as the principal cause of an increase in incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous geographic regions around the world. Further study of the epidemiology of HPV-positive HNC will be critical to the development and implementation of public health interventions to reverse these global incidence trends. Here, recent data are reviewed to provide insight into several topics, including incidence trends and projections for HPV-positive HNC; the worldwide HPV-attributable fraction; sex disparities in cancer risk; the epidemiology of oral HPV infection; the latency period between infection and cancer; the potential impact of prophylactic HPV vaccination; and prospects for secondary prevention through screening for oral HPV infection or seroreactivity to viral antigens. The identification of a single necessary cause for any cancer provides a rare and perhaps extraordinary opportunity for cancer prevention.
© 2015 by American Society of Clinical Oncology.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest are found in the article online at
Figures
Similar articles
-
Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.Head Neck Pathol. 2017 Sep;11(3):377-384. doi: 10.1007/s12105-017-0780-7. Epub 2017 Feb 7. Head Neck Pathol. 2017. PMID: 28176136 Free PMC article. Review.
-
Epidemiology of human papillomavirus-related head and neck cancer.Otolaryngol Clin North Am. 2012 Aug;45(4):739-64. doi: 10.1016/j.otc.2012.04.003. Epub 2012 May 31. Otolaryngol Clin North Am. 2012. PMID: 22793850 Review.
-
Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?Cancer. 2007 Oct 1;110(7):1429-35. doi: 10.1002/cncr.22963. Cancer. 2007. PMID: 17724670 Review.
-
Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.Cancer. 2017 Jun 15;123(12):2219-2229. doi: 10.1002/cncr.30588. Epub 2017 Mar 27. Cancer. 2017. PMID: 28346680 Review.
-
Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):763-5. doi: 10.1586/14737167.2014.946012. Epub 2014 Aug 6. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 25095728 Review.
Cited by
-
Retrospective study of the clinicopathological characteristics and prognosis of elderly patients with oropharyngeal squamous cell carcinoma.J Int Med Res. 2021 Jun;49(6):3000605211016662. doi: 10.1177/03000605211016662. J Int Med Res. 2021. PMID: 34082601 Free PMC article.
-
Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.J Transl Med. 2020 Jun 16;18(1):240. doi: 10.1186/s12967-020-02396-8. J Transl Med. 2020. PMID: 32546279 Free PMC article.
-
18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002.J Nucl Med. 2023 Mar;64(3):362-367. doi: 10.2967/jnumed.122.264424. Epub 2022 Sep 2. J Nucl Med. 2023. PMID: 36215572 Free PMC article. Clinical Trial.
-
Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines.Cancers (Basel). 2021 Mar 3;13(5):1069. doi: 10.3390/cancers13051069. Cancers (Basel). 2021. PMID: 33802339 Free PMC article.
-
Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression.Cells. 2021 Feb 13;10(2):389. doi: 10.3390/cells10020389. Cells. 2021. PMID: 33668576 Free PMC article. Review.
References
-
- International Agency for Research on Cancer (ed) Human Papillomaviruses. Lyon, France: World Health Organization; 2007. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; p. 670.
-
- Gillison ML, Alemany L, Snijders PJ, et al. Human papillomavirus and diseases of the upper airway: Head and neck cancer and respiratory papillomatosis. Vaccine. 2012;30(suppl 5):F34–F54. - PubMed
-
- Gillison ML, Castellsagué X, Chaturvedi A, et al. Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer. 2014;134:497–507. - PubMed
-
- Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620–2623. - PubMed
-
- Hong A, Lee CS, Jones D, et al. Rising prevalence of human papillomavirus related oropharyngeal cancer in Australia over the last two decades. Head Neck. [epub ahead of print on December 18, 2014] - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical